The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ALLERGAN PLC | COM | G0177J908 | 11,516 | 50,000 | SH | Call | SOLE | 50,000 | 0 | 0 | |
| BRISTOL MYERS SQUIBB CO | COM | 110122908 | 26,960 | 500,000 | SH | Call | SOLE | 500,000 | 0 | 0 | |
| CASCADIAN THERAPEUTICS INC | COM | 14740B901 | 170 | 103,800 | SH | Call | SOLE | 103,800 | 0 | 0 | |
| EXACT SCIENCES CORP | COM | 30063P955 | 9,285 | 500,000 | SH | Put | SOLE | 500,000 | 0 | 0 | |
| GILEAD SCIENCES INC | COM | 375558903 | 11,868 | 150,000 | SH | Call | SOLE | 150,000 | 0 | 0 | |
| IRONWOOD PHARMACEUTICALS INC | COM | 46333X908 | 4,470 | 281,500 | SH | Call | SOLE | 281,500 | 0 | 0 | |
| ASCENDIS PHARMA A S | SPONSORED ADR | 04351P101 | 4,406 | 219,200 | SH | SOLE | 219,200 | 0 | 0 | ||
| BEIGENE LTD | SPONSORED ADR | 07725L102 | 5,037 | 163,470 | SH | SOLE | 163,470 | 0 | 0 | ||
| GALAPAGOS NV | SPONSORED ADR | 36315X101 | 32,367 | 500,576 | SH | SOLE | 500,576 | 0 | 0 | ||
| NABRIVA THERAPEUTICS AG | SPONSORED ADR | 62957M104 | 3,870 | 548,912 | SH | SOLE | 548,912 | 0 | 0 | ||
| ADVERUM BIOTECHNOLOGIES INC | COM | 00773U108 | 3,889 | 946,263 | SH | SOLE | 946,263 | 0 | 0 | ||
| AGIOS PHARMACEUTICALS INC | COM | 00847X104 | 10,564 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| ACHAOGEN INC | COM | 004449104 | 8,046 | 1,679,707 | SH | SOLE | 1,679,707 | 0 | 0 | ||
| ARDELYX INC | COM | 039697107 | 16,952 | 1,310,023 | SH | SOLE | 1,310,023 | 0 | 0 | ||
| ASSEMBLY BIOSCIENCES INC | COM | 045396108 | 21,220 | 2,943,164 | SH | SOLE | 2,943,164 | 0 | 0 | ||
| CHEMOCENTRYX INC | COM | 01683L106 | 1,075 | 178,000 | SH | SOLE | 178,000 | 0 | 0 | ||
| CHIMERIX INC | COM | 16934W106 | 3,313 | 598,062 | SH | SOLE | 598,062 | 0 | 0 | ||
| CYTOKINETICS INC | COM | 23282W605 | 7,772 | 846,654 | SH | SOLE | 846,654 | 0 | 0 | ||
| DERMIRA INC | COM | 24983L104 | 17,654 | 522,000 | SH | SOLE | 522,000 | 0 | 0 | ||
| FATE THERAPEUTICS INC | COM | 31189P102 | 1,842 | 590,527 | SH | SOLE | 590,527 | 0 | 0 | ||
| FIBROGEN INC | COM | 31572Q808 | 14,204 | 686,184 | SH | SOLE | 686,184 | 0 | 0 | ||
| FIVE PRIME THERAPEUTICS INC | COM | 33830X104 | 15,044 | 286,612 | SH | SOLE | 286,612 | 0 | 0 | ||
| IRONWOOD PHARMACEUTICALS INC | COM | 46333X108 | 44,628 | 2,810,315 | SH | SOLE | 2,810,315 | 0 | 0 | ||
| KINDRED BIOSCIENCES INC | COM | 494577109 | 7,149 | 1,432,765 | SH | SOLE | 1,432,765 | 0 | 0 | ||
| KURA ONCOLOGY INC | COM | 50127T109 | 16,324 | 2,611,906 | SH | SOLE | 2,611,906 | 0 | 0 | ||
| SPARK THERAPEUTICS INC | COM | 84652J103 | 4,120 | 68,600 | SH | SOLE | 68,600 | 0 | 0 | ||
| SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 5,418 | 357,365 | SH | SOLE | 357,365 | 0 | 0 | ||
| SYROS PHARMACEUTICALS INC | COM | 87184Q107 | 882 | 63,596 | SH | SOLE | 63,596 | 0 | 0 | ||
| ONCOMED PHARMACEUTICALS INC | COM | 68234X102 | 3,038 | 265,784 | SH | SOLE | 265,784 | 0 | 0 | ||
| PROTEOSTASIS THERAPEUTICS INC | COM | 74373B109 | 9,390 | 602,315 | SH | SOLE | 602,315 | 0 | 0 | ||
| INTELLIA THERAPEUTICS INC | COM | 45826J105 | 3,419 | 200,858 | SH | SOLE | 200,858 | 0 | 0 | ||